vs

Side-by-side financial comparison of Camden Property Trust (CPT) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Lakeside Holding Ltd is the larger business by last-quarter revenue ($7.0M vs $5.3M, roughly 1.3× Camden Property Trust). Camden Property Trust runs the higher net margin — 2954.1% vs -22.6%, a 2976.7% gap on every dollar of revenue. On growth, Camden Property Trust posted the faster year-over-year revenue change (243.0% vs 95.0%).

Camden Property Trust is a publicly traded real estate investment trust that invests in apartments in the United States. As of December 31, 2023, the company owned interests in 176 apartment communities containing 59,800 apartment homes in the United States. It is the 14th largest owner of apartments in the United States.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

CPT vs LSH — Head-to-Head

Bigger by revenue
LSH
LSH
1.3× larger
LSH
$7.0M
$5.3M
CPT
Growing faster (revenue YoY)
CPT
CPT
+148.0% gap
CPT
243.0%
95.0%
LSH
Higher net margin
CPT
CPT
2976.7% more per $
CPT
2954.1%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPT
CPT
LSH
LSH
Revenue
$5.3M
$7.0M
Net Profit
$156.0M
$-1.6M
Gross Margin
27.2%
Operating Margin
-21.3%
Net Margin
2954.1%
-22.6%
Revenue YoY
243.0%
95.0%
Net Profit YoY
283.5%
18.7%
EPS (diluted)
$1.44
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPT
CPT
LSH
LSH
Q4 25
$5.3M
$7.0M
Q3 25
$2.6M
$6.1M
Q2 25
$2.6M
$6.3M
Q1 25
$2.5M
$3.8M
Q4 24
$1.5M
$3.6M
Q3 24
$1.7M
$4.1M
Q2 24
$2.6M
Q1 24
$1.3M
Net Profit
CPT
CPT
LSH
LSH
Q4 25
$156.0M
$-1.6M
Q3 25
$108.9M
$-1.4M
Q2 25
$80.7M
$-893.1K
Q1 25
$38.8M
$-1.1M
Q4 24
$40.7M
$-1.9M
Q3 24
$-4.2M
$-1.3M
Q2 24
$42.9M
Q1 24
$83.9M
Gross Margin
CPT
CPT
LSH
LSH
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
CPT
CPT
LSH
LSH
Q4 25
-21.3%
Q3 25
-20.8%
Q2 25
-8.9%
Q1 25
-28.2%
Q4 24
-55.6%
Q3 24
-32.5%
Q2 24
Q1 24
Net Margin
CPT
CPT
LSH
LSH
Q4 25
2954.1%
-22.6%
Q3 25
4246.9%
-22.2%
Q2 25
3063.8%
-14.2%
Q1 25
1561.0%
-28.2%
Q4 24
2642.3%
-54.1%
Q3 24
-246.3%
-32.7%
Q2 24
1646.9%
Q1 24
6533.4%
EPS (diluted)
CPT
CPT
LSH
LSH
Q4 25
$1.44
$-0.08
Q3 25
$1.00
$-0.09
Q2 25
$0.74
$-0.11
Q1 25
$0.36
$-0.14
Q4 24
$0.37
$-0.26
Q3 24
$-0.04
$-0.18
Q2 24
$0.40
Q1 24
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPT
CPT
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$25.2M
$1.6M
Total DebtLower is stronger
$3.9B
$2.4M
Stockholders' EquityBook value
$4.4B
$12.2M
Total Assets
$9.0B
$24.3M
Debt / EquityLower = less leverage
0.89×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPT
CPT
LSH
LSH
Q4 25
$25.2M
$1.6M
Q3 25
$25.9M
$4.5M
Q2 25
$33.1M
$5.0M
Q1 25
$26.2M
$1.5M
Q4 24
$21.0M
$1.1M
Q3 24
$31.2M
$2.7M
Q2 24
$93.9M
Q1 24
$92.7M
Total Debt
CPT
CPT
LSH
LSH
Q4 25
$3.9B
$2.4M
Q3 25
$3.7B
$2.4M
Q2 25
$3.8B
$1.4M
Q1 25
$3.7B
$774.2K
Q4 24
$3.5B
$784.8K
Q3 24
$3.5B
$589.9K
Q2 24
$3.6B
Q1 24
$3.6B
Stockholders' Equity
CPT
CPT
LSH
LSH
Q4 25
$4.4B
$12.2M
Q3 25
$4.5B
$7.0M
Q2 25
$4.6B
$2.8M
Q1 25
$4.6B
$749.8K
Q4 24
$4.7B
$1.6M
Q3 24
$4.7B
$3.6M
Q2 24
$4.9B
Q1 24
$4.9B
Total Assets
CPT
CPT
LSH
LSH
Q4 25
$9.0B
$24.3M
Q3 25
$9.1B
$18.6M
Q2 25
$9.1B
$14.4M
Q1 25
$9.0B
$9.9M
Q4 24
$8.9B
$9.8M
Q3 24
$8.9B
$10.8M
Q2 24
$9.1B
Q1 24
$9.1B
Debt / Equity
CPT
CPT
LSH
LSH
Q4 25
0.89×
0.20×
Q3 25
0.82×
0.35×
Q2 25
0.83×
0.48×
Q1 25
0.81×
1.03×
Q4 24
0.75×
0.48×
Q3 24
0.73×
0.16×
Q2 24
0.73×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPT
CPT
LSH
LSH
Operating Cash FlowLast quarter
$826.6M
$-453.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
5.30×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPT
CPT
LSH
LSH
Q4 25
$826.6M
$-453.5K
Q3 25
$250.9M
$-4.0M
Q2 25
$230.7M
$-483.7K
Q1 25
$148.2M
$-238.3K
Q4 24
$774.9M
$-530.2K
Q3 24
$261.6M
$-1.4M
Q2 24
$225.1M
Q1 24
$135.9M
Free Cash Flow
CPT
CPT
LSH
LSH
Q4 25
Q3 25
Q2 25
$-497.4K
Q1 25
Q4 24
$-560.5K
Q3 24
$-1.4M
Q2 24
Q1 24
FCF Margin
CPT
CPT
LSH
LSH
Q4 25
Q3 25
Q2 25
-7.9%
Q1 25
Q4 24
-15.6%
Q3 24
-34.5%
Q2 24
Q1 24
Capex Intensity
CPT
CPT
LSH
LSH
Q4 25
Q3 25
Q2 25
0.2%
Q1 25
0.0%
Q4 24
0.8%
Q3 24
0.1%
Q2 24
Q1 24
Cash Conversion
CPT
CPT
LSH
LSH
Q4 25
5.30×
Q3 25
2.30×
Q2 25
2.86×
Q1 25
3.82×
Q4 24
19.04×
Q3 24
Q2 24
5.24×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPT
CPT

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons